Amyris Inc (AMRSQ)

[BioPartners71]

Actually, Amyris, Inc. (AMRS) is trading far less than their intrinsic worth. To identify the value, you need to look at the growth % in the least 3 qtrs to identify a value strategy. I believe they will turn into a growth play (trading above Intrinsic value) (1.83 pps) by end of Q2 17'.

They are working on synthetic Antibiotics with a big pharma partner to combat Bacterial Resistance to the natural derived antibiotics. This alone makes their IP quite valuable.

Last, Sept CC they unveiled that they will announce another partnership in Q1 2017 that will use their applications in the Food Sector. Dec, during an interview, John hinted they're excited to get into the sugar reduction market - ex: Soft Drinks (Start at 3:20)

I believe they will announce a partnership with a big soft drink conglomerate (Coke or Pepsico) in a few months.